HIMS vs STLN: stock comparison and AI forecast
Hims & Hers Health, Inc. (HIMS) and Starling Oncology, Inc. (STLN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
HIMS Hims & Hers Health, Inc.
- Price
- $25.24 -7.4% · 6M
- Market Cap
- $5.85B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
STLN Starling Oncology, Inc.
- Price
- $6.25 +53.2% · 6M
- Market Cap
- $615M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- HIMS is 9.5 times larger than STLN by market capitalization ($5.85B against $615M).
- Over the last six months STLN returned +53.2% and HIMS -7.4%.
- Both companies share the SEC industry classification Services-Offices & Clinics of Doctors of Medicine.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | HIMS | STLN |
|---|---|---|
| Market Cap | $5.85B | $615M |
| P/B Ratio | 18.05x | – |
| EPS | $-0.03 | $-0.47 |
| Book Value/Share | $1.42 | – |
| Revenue/Share | $11.33 | $5.97 |
| FCF/Share | $0.27 | $-0.03 |
Profitability & Margins
| Metric | HIMS | STLN |
|---|---|---|
| ROA | – | -20.4% |
| ROIC | -7.2% | -31.3% |
| Gross Margin | 68.4% | – |
| Operating Margin | -6.0% | -4.4% |
| Net Margin | – | -6.2% |
| EBT Margin | -6.3% | -6.2% |
| Tax Rate | 13.2% | 0.0% |
Financial Health
| Metric | HIMS | STLN |
|---|---|---|
| Current Ratio | 0.93x | 1.36x |
| Quick Ratio | 0.87x | 1.15x |
| D/E Ratio | 10.20x | – |
| Financial Leverage | 11.20x | – |
| Interest Coverage | -141.9x | -5.3x |
| Working Capital | -$99M | $34M |
Cash Flow
| Metric | HIMS | STLN |
|---|---|---|
| Operating Cash Flow | $263M | $330K |
| Free Cash Flow | $62M | -$3M |
| Capital Spending | -$202M | -$4M |
| OCF Growth YoY | 0.7% | – |
| FCF/Sales | 2.4% | -0.6% |
| CapEx/Sales | 7.8% | 0.6% |
Operational Efficiency
| Metric | HIMS | STLN |
|---|---|---|
| Asset Turnover | 0.71x | 3.29x |
| Receivables Turnover | 6.9x | 8.8x |
| Inventory Turnover | 9.3x | – |
| Fixed Assets Turnover | – | 55.5x |
| Days Sales Outstanding | 53 days | 41 days |
| Days Inventory | 39 days | – |
| Payables Period | 225 days | – |
| Cash Conversion Cycle | -132 days | – |
Income Statement
| Metric | HIMS | STLN |
|---|---|---|
| Total Revenue | $2.58B | $587M |
| Operating Income | -$155M | -$26M |
| Net Income | – | -$36M |
| SG&A Expense | – | $111M |
| Cost of Goods Sold | $814M | – |
Dividend & Shareholder Information
| Metric | HIMS | STLN |
|---|---|---|
| Shares Outstanding | 228M | 98M |
| EPS Growth | -104.7% | – |
HIMS vs STLN: stock comparison and AI forecast
Which is bigger, HIMS or STLN?
HIMS is 9.5 times larger than STLN by market capitalization ($5.85B against $615M).
Which stock performed better over the last six months, HIMS or STLN?
Over the last six months STLN returned +53.2% and HIMS -7.4%.
Which one does Intratio's AI model rank higher, HIMS or STLN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.